• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估结直肠肝转移可切除性的一致性:一项全国范围内基于病例的肝外科医生调查。

Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons.

机构信息

Liver and Pancreas Unit, Division of General Surgery, The Ottawa Hospital, University of Ottawa, Ontario, Canada.

出版信息

HPB (Oxford). 2012 May;14(5):291-7. doi: 10.1111/j.1477-2574.2012.00440.x. Epub 2012 Feb 9.

DOI:10.1111/j.1477-2574.2012.00440.x
PMID:22487066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3384848/
Abstract

BACKGROUND

The resectability of colorectal liver metastases is in part largely based on the surgeon's assessment of cross-sectional imaging. This process, while guided by principles, is subjective. The objective of the present study was to assess agreement between hepatic surgeons regarding the resectability of colorectal liver metastases.

METHODS

Forty-six hepatic surgeons across Canada were invited. A patient with biologically favourable disease was presented after having received neoadjuvant chemotherapy. The scenario was matched with 10 different scrollable abdominal CT scans representing a maximum response after six cycles of chemotherapy. Surgeons were asked to offer an opinion on resectability of liver metastases, and whether they would use adjunct modalities to hepatic resection.

RESULTS

Twenty-six surgeons participated. Twenty responses were complete. The median number of scenarios deemed resectable was 6/10 (range 3-8). Two control scenarios demonstrated perfect agreement. Agreement on resectability was poor for 4/8 test scenarios, of which one scenario demonstrated complete disagreement. Among resectable cases, the pattern of use of adjunct modalities was variable. A median ratio of 0.87 adjunct modality per resectable scenario per surgeon was used (range 0.25-1.75).

CONCLUSION

A significant lack of agreement was identified among surgeons on the resectability and use of adjunct modalities in the treatment of colorectal liver metastases.

摘要

背景

结直肠肝转移的可切除性在很大程度上取决于外科医生对横断面成像的评估。尽管这一过程有原则可循,但仍具有主观性。本研究的目的是评估肝脏外科医生对结直肠肝转移可切除性的意见是否一致。

方法

邀请了加拿大各地的 46 名肝脏外科医生。一名接受新辅助化疗后患有生物有利疾病的患者被纳入研究。该病例与 10 个不同的滚动式腹部 CT 扫描匹配,这些扫描代表了化疗 6 个周期后的最大反应。外科医生被要求对肝转移的可切除性以及是否使用辅助肝脏切除术的方法发表意见。

结果

26 名外科医生参与了研究。20 名外科医生提供了完整的回复。中位数认为可切除的病例数为 6/10(范围 3-8)。两个对照病例完全一致。在 8 个测试病例中,有 4 个病例的可切除性意见不一致,其中一个病例完全不一致。在可切除的病例中,辅助治疗方法的使用模式存在差异。中位数每个可切除病例每个外科医生使用 0.87 个辅助治疗方法(范围 0.25-1.75)。

结论

研究表明,外科医生在结直肠肝转移的可切除性和辅助治疗方法的使用方面存在显著的意见不一致。

相似文献

1
Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons.评估结直肠肝转移可切除性的一致性:一项全国范围内基于病例的肝外科医生调查。
HPB (Oxford). 2012 May;14(5):291-7. doi: 10.1111/j.1477-2574.2012.00440.x. Epub 2012 Feb 9.
2
Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.新辅助化疗后原发性不可切除结直肠癌肝转移灶的可切除性评估:一项多中心研究。
Eur J Surg Oncol. 2016 Feb;42(2):184-9. doi: 10.1016/j.ejso.2015.11.007. Epub 2015 Nov 22.
3
Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?评估结直肠癌肝转移的可切除性:不同亚专业如何解读相同的数据?
Can J Surg. 2018 Aug;61(4):251-256. doi: 10.1503/cjs.014616.
4
Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario?评估肝脏结直肠癌转移的管理:安大略省的治疗方法是否一致?
HPB (Oxford). 2012 Jun;14(6):409-13. doi: 10.1111/j.1477-2574.2012.00467.x. Epub 2012 Apr 19.
5
Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.治疗结直肠癌肝转移的肿瘤内科医生的手术切除偏好与认知
Ann Surg Oncol. 2016 Feb;23(2):375-81. doi: 10.1245/s10434-015-4925-1. Epub 2015 Nov 11.
6
Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.泛欧调查:初诊可切除结直肠癌肝转移患者的当前治疗策略。
HPB (Oxford). 2024 May;26(5):639-647. doi: 10.1016/j.hpb.2024.01.007. Epub 2024 Jan 29.
7
Resectability of colorectal liver metastases: an evolving definition.结直肠癌肝转移的可切除性:一个不断演变的定义。
HPB (Oxford). 2012 May;14(5):283-4. doi: 10.1111/j.1477-2574.2012.00451.x. Epub 2012 Mar 19.
8
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.西妥昔单抗新辅助化疗后结直肠癌肝转移的肿瘤反应和二次可切除性:CELIM 随机 2 期试验。
Lancet Oncol. 2010 Jan;11(1):38-47. doi: 10.1016/S1470-2045(09)70330-4. Epub 2009 Nov 26.
9
OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.OncoSurge:转移性结直肠癌的长期生存策略。
Colorectal Dis. 2003 Nov;5 Suppl 3:20-8. doi: 10.1046/j.1463-1318.5.s3.1.x.
10
The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry.ALPPS的多面性:参与国际登记处的外科医生的手术适应症和技术
HPB (Oxford). 2016 May;18(5):442-8. doi: 10.1016/j.hpb.2016.01.547. Epub 2016 Mar 10.

引用本文的文献

1
Rethinking surrogate endpoints in metastatic colorectal cancer: counting chickens only when they hatch.重新审视转移性结直肠癌的替代终点:蛋未孵化,勿数小鸡。
J Gastrointest Oncol. 2025 Aug 30;16(4):1763-1767. doi: 10.21037/jgo-2025-386. Epub 2025 Aug 25.
2
Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives.结直肠癌肝转移的预后因素:文献综述及未来展望
Cancers (Basel). 2025 Jul 31;17(15):2539. doi: 10.3390/cancers17152539.
3
Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases.结直肠癌肝转移精准手术面临的挑战与机遇
Cancers (Basel). 2024 Jun 28;16(13):2379. doi: 10.3390/cancers16132379.
4
Contemporary Surgical Management of Colorectal Liver Metastases.结直肠癌肝转移的现代外科治疗
Cancers (Basel). 2024 Feb 26;16(5):941. doi: 10.3390/cancers16050941.
5
Comparing a virtual reality head-mounted display to on-screen three-dimensional visualization and two-dimensional computed tomography data for training in decision making in hepatic surgery: a randomized controlled study.虚拟现实头戴式显示器与屏幕三维可视化和二维计算机断层扫描数据在肝外科决策训练中的比较:一项随机对照研究。
Surg Endosc. 2024 May;38(5):2483-2496. doi: 10.1007/s00464-023-10615-8. Epub 2024 Mar 8.
6
Protocol for the CoNoR Study: A prospective multi-step study of the potential added benefit of two novel assessment tools in colorectal liver metastases technical resectability decision-making.CoNoR 研究方案:一项前瞻性多步研究,旨在评估两种新型评估工具在结直肠肝转移技术可切除性决策中的潜在附加获益。
BMJ Open. 2023 Mar 30;13(3):e059369. doi: 10.1136/bmjopen-2021-059369.
7
Current Surgical Management Strategies for Colorectal Cancer Liver Metastases.结直肠癌肝转移的当前外科治疗策略
Cancers (Basel). 2022 Feb 20;14(4):1063. doi: 10.3390/cancers14041063.
8
Alveolar Echinococcosis-A Challenging Task for the Hepatobiliary Surgeon.肺泡型肝包虫病——肝胆外科医生面临的一项具有挑战性的任务。
Pathogens. 2021 Dec 31;11(1):40. doi: 10.3390/pathogens11010040.
9
[Why are too few patients with colorectal liver metastases submitted to resection?].[为什么接受手术切除的结直肠癌肝转移患者如此之少?]
Chirurg. 2021 Aug;92(8):736-741. doi: 10.1007/s00104-021-01363-3. Epub 2021 Feb 18.
10
Assessing resectability for colorectal liver metastases: agreeing that we disagree.评估结直肠癌肝转移的可切除性:我们虽有分歧,但达成共识。
Hepatobiliary Surg Nutr. 2020 Dec;9(6):797-800. doi: 10.21037/hbsn.2020.03.25.

本文引用的文献

1
Measuring processes of care in general surgery: assessment of technical and nontechnical skills.普通外科护理过程的测量:技术和非技术技能评估
Surg Innov. 2010 Dec;17(4):332-9. doi: 10.1177/1553350610379426. Epub 2010 Aug 25.
2
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
3
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.西妥昔单抗新辅助化疗后结直肠癌肝转移的肿瘤反应和二次可切除性:CELIM 随机 2 期试验。
Lancet Oncol. 2010 Jan;11(1):38-47. doi: 10.1016/S1470-2045(09)70330-4. Epub 2009 Nov 26.
4
Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.IV期结肠癌和直肠癌患者在多学科团队评估与治疗方面的差异。
Colorectal Dis. 2009 Sep;11(7):768-74. doi: 10.1111/j.1463-1318.2008.01648.x. Epub 2008 Jul 25.
5
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities].[影像学在结直肠癌肝转移及肝外异常诊断中的应用]
Ned Tijdschr Geneeskd. 2008 Apr 12;152(15):857-62.
6
Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.结直肠癌肝转移的肝脏手术:10年随访结果。长期生存者、晚期复发及并发症的预后作用。
Ann Surg Oncol. 2008 Sep;15(9):2458-64. doi: 10.1245/s10434-008-9935-9. Epub 2008 May 8.
7
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases.
Br J Cancer. 2007 Oct 22;97(8):1035-9. doi: 10.1038/sj.bjc.6603988. Epub 2007 Sep 25.
8
Surgical therapy for colorectal metastases to the liver.结直肠癌肝转移的外科治疗
J Gastrointest Surg. 2007 Aug;11(8):1057-77. doi: 10.1007/s11605-006-0061-3.
9
Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients.扩大适应证患者结直肠癌肝转移的手术切除:501例患者的单中心经验
Dis Colon Rectum. 2007 Apr;50(4):478-88. doi: 10.1007/s10350-006-0817-6.
10
Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.肝结直肠癌转移灶切除术患者的选择:专家共识声明
Ann Surg Oncol. 2006 Oct;13(10):1261-8. doi: 10.1245/s10434-006-9023-y. Epub 2006 Sep 1.